Summary Chiome Bioscience Inc (Chiome Bioscience) is a healthcare service company that offers research and development of therapies. The company research and develops antibody drugs for the treatment of autoimmune and inflammatory diseases. Its ADLib system is a monoclonal antibody generating system provides various arrays of antibodies in vitro, without using immunization. Chiome Bioscience uses the ADLib system to generate therapeutic antibodies, prepares antibodies against antigens and licenses them out to pharmaceutical manufacturers, and licenses the ADLib system. The company discovers monoconal antibody through ADLib system. It serves drug discovery companies, drug manufacturers and biotech companies to develop antibody drugs through programs. The company operates through its laboratory located in Kanagawa, Japan. Chiome Bioscience is headquartered in Tokyo, Japan. Chiome Bioscience Inc (4583) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over... Research Beam Model: Research Beam Product ID: 1916014 250 USD New
Chiome Bioscience Inc (4583) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Chiome Bioscience Inc (4583) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : July   2017
  • Pages : 22
  • Publisher : GlobalData
 
 
 
Summary

Chiome Bioscience Inc (Chiome Bioscience) is a healthcare service company that offers research and development of therapies. The company research and develops antibody drugs for the treatment of autoimmune and inflammatory diseases. Its ADLib system is a monoclonal antibody generating system provides various arrays of antibodies in vitro, without using immunization. Chiome Bioscience uses the ADLib system to generate therapeutic antibodies, prepares antibodies against antigens and licenses them out to pharmaceutical manufacturers, and licenses the ADLib system. The company discovers monoconal antibody through ADLib system. It serves drug discovery companies, drug manufacturers and biotech companies to develop antibody drugs through programs. The company operates through its laboratory located in Kanagawa, Japan. Chiome Bioscience is headquartered in Tokyo, Japan.

Chiome Bioscience Inc (4583) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Chiome Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Chiome Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Chiome Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Chiome Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Chiome Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Chiome Bioscience Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Fusion Antibodies Enters into Agreement with Chiome Bioscience 10
Shin Nippon Biomedical Labs To Enter Co-Development Agreement With Chiome Bioscience 10
Chiome Bioscience Enters Into Co-Development Agreement With National Cancer Center Hospital 11
Chiome Bioscience Enters Into Co-Development Agreement With Yokohama City University 12
Chiome Bioscience Enters Into Co-Development Agreement With Shizuoka Cancer Center 12
Licensing Agreements 13
ADC Therapeutics Exercises Option for Licensing Agreement with LivTech 13
Chiome Bioscience Enters Into Licensing Agreement With RIKEN 14
LivTech Enters Into Option For Licensing Agreement With Yakult Honsha For Liv-2008 14
Equity Offering 15
Chiome Bioscience Completes IPO For US$6.6 Million 15
Acquisition 17
Chiome Bioscience to Acquire 6.3% Stake in Trans Chromosomics for USD1.3 Million 17
Chiome Bioscience Acquires Remaining Stake in LivTech 17
Chiome Bioscience Acquires 52.9% Stake in LivTech for USD0.8 Million 18
Chiome Bioscience Inc - Key Competitors 19
Key Employees 20
Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List of Tables
Chiome Bioscience Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Chiome Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Chiome Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Chiome Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Chiome Bioscience Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Chiome Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Fusion Antibodies Enters into Agreement with Chiome Bioscience 10
Shin Nippon Biomedical Labs To Enter Co-Development Agreement With Chiome Bioscience 10
Chiome Bioscience Enters Into Co-Development Agreement With National Cancer Center Hospital 11
Chiome Bioscience Enters Into Co-Development Agreement With Yokohama City University 12
Chiome Bioscience Enters Into Co-Development Agreement With Shizuoka Cancer Center 12
ADC Therapeutics Exercises Option for Licensing Agreement with LivTech 13
Chiome Bioscience Enters Into Licensing Agreement With RIKEN 14
LivTech Enters Into Option For Licensing Agreement With Yakult Honsha For Liv-2008 14
Chiome Bioscience Completes IPO For US$6.6 Million 15
Chiome Bioscience to Acquire 6.3% Stake in Trans Chromosomics for USD1.3 Million 17
Chiome Bioscience Acquires Remaining Stake in LivTech 17
Chiome Bioscience Acquires 52.9% Stake in LivTech for USD0.8 Million 18
Chiome Bioscience Inc, Key Competitors 19
Chiome Bioscience Inc, Key Employees 20
Chiome Bioscience Inc, Subsidiaries 21List of Figures
Chiome Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Chiome Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Chiome Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Chiome Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Chiome Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Chiome Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Chiome Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Chiome Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter